nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CES1—Tamoxifen—pancreatic cancer	0.37	0.449	CbGbCtD
Ciclesonide—CES1—Irinotecan—pancreatic cancer	0.284	0.345	CbGbCtD
Ciclesonide—CYP2D6—Tamoxifen—pancreatic cancer	0.0343	0.0417	CbGbCtD
Ciclesonide—CYP2D6—Erlotinib—pancreatic cancer	0.0292	0.0355	CbGbCtD
Ciclesonide—CYP3A4—Tamoxifen—pancreatic cancer	0.0218	0.0265	CbGbCtD
Ciclesonide—CYP3A4—Erlotinib—pancreatic cancer	0.0185	0.0225	CbGbCtD
Ciclesonide—CYP3A4—Irinotecan—pancreatic cancer	0.0167	0.0204	CbGbCtD
Ciclesonide—CYP2D6—Doxorubicin—pancreatic cancer	0.0144	0.0175	CbGbCtD
Ciclesonide—CYP3A4—Docetaxel—pancreatic cancer	0.0123	0.0149	CbGbCtD
Ciclesonide—CYP3A4—Sunitinib—pancreatic cancer	0.0122	0.0149	CbGbCtD
Ciclesonide—CYP3A4—Doxorubicin—pancreatic cancer	0.00915	0.0111	CbGbCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00221	0.15	CbGpPWpGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.00111	0.0753	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—FGF13—pancreatic cancer	0.000969	0.0659	CbGpPWpGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000878	0.0597	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—RBBP8—pancreatic cancer	0.000734	0.0499	CbGpPWpGaD
Ciclesonide—Dysphonia—Epirubicin—pancreatic cancer	0.000593	0.00364	CcSEcCtD
Ciclesonide—Angioedema—Tamoxifen—pancreatic cancer	0.000593	0.00364	CcSEcCtD
Ciclesonide—Pneumonia—Irinotecan—pancreatic cancer	0.000589	0.00361	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.000585	0.00359	CcSEcCtD
Ciclesonide—Immune system disorder—Sunitinib—pancreatic cancer	0.000577	0.00354	CcSEcCtD
Ciclesonide—Mediastinal disorder—Sunitinib—pancreatic cancer	0.000575	0.00353	CcSEcCtD
Ciclesonide—Pneumonia—Gemcitabine—pancreatic cancer	0.000574	0.00352	CcSEcCtD
Ciclesonide—Cough—Tamoxifen—pancreatic cancer	0.000566	0.00347	CcSEcCtD
Ciclesonide—Pneumonia—Fluorouracil—pancreatic cancer	0.000564	0.00346	CcSEcCtD
Ciclesonide—Infestation—Fluorouracil—pancreatic cancer	0.000561	0.00344	CcSEcCtD
Ciclesonide—Infestation NOS—Fluorouracil—pancreatic cancer	0.000561	0.00344	CcSEcCtD
Ciclesonide—Hypertension—Tamoxifen—pancreatic cancer	0.00056	0.00344	CcSEcCtD
Ciclesonide—Cough—Erlotinib—pancreatic cancer	0.00056	0.00344	CcSEcCtD
Ciclesonide—Arthralgia—Tamoxifen—pancreatic cancer	0.000552	0.00339	CcSEcCtD
Ciclesonide—Chest pain—Tamoxifen—pancreatic cancer	0.000552	0.00339	CcSEcCtD
Ciclesonide—Dysphonia—Doxorubicin—pancreatic cancer	0.000549	0.00337	CcSEcCtD
Ciclesonide—Arthralgia—Erlotinib—pancreatic cancer	0.000547	0.00335	CcSEcCtD
Ciclesonide—Chest pain—Erlotinib—pancreatic cancer	0.000547	0.00335	CcSEcCtD
Ciclesonide—Conjunctivitis—Fluorouracil—pancreatic cancer	0.000545	0.00335	CcSEcCtD
Ciclesonide—Urinary tract infection—Fluorouracil—pancreatic cancer	0.000545	0.00335	CcSEcCtD
Ciclesonide—Dysgeusia—Sunitinib—pancreatic cancer	0.000544	0.00334	CcSEcCtD
Ciclesonide—Dry mouth—Tamoxifen—pancreatic cancer	0.00054	0.00331	CcSEcCtD
Ciclesonide—Back pain—Sunitinib—pancreatic cancer	0.000538	0.0033	CcSEcCtD
Ciclesonide—Epistaxis—Fluorouracil—pancreatic cancer	0.000529	0.00325	CcSEcCtD
Ciclesonide—Haemoglobin—Irinotecan—pancreatic cancer	0.000529	0.00324	CcSEcCtD
Ciclesonide—Rhinitis—Irinotecan—pancreatic cancer	0.000527	0.00323	CcSEcCtD
Ciclesonide—Sinusitis—Fluorouracil—pancreatic cancer	0.000526	0.00323	CcSEcCtD
Ciclesonide—Infection—Tamoxifen—pancreatic cancer	0.000526	0.00323	CcSEcCtD
Ciclesonide—Haemorrhage—Irinotecan—pancreatic cancer	0.000526	0.00323	CcSEcCtD
Ciclesonide—Pain in extremity—Docetaxel—pancreatic cancer	0.000525	0.00322	CcSEcCtD
Ciclesonide—Infection—Erlotinib—pancreatic cancer	0.000521	0.00319	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptors—NR5A2—pancreatic cancer	0.00052	0.0354	CbGpPWpGaD
Ciclesonide—Ulcer—Epirubicin—pancreatic cancer	0.000516	0.00317	CcSEcCtD
Ciclesonide—Haemoglobin—Gemcitabine—pancreatic cancer	0.000515	0.00316	CcSEcCtD
Ciclesonide—Rhinitis—Gemcitabine—pancreatic cancer	0.000514	0.00315	CcSEcCtD
Ciclesonide—Haemorrhage—Gemcitabine—pancreatic cancer	0.000512	0.00314	CcSEcCtD
Ciclesonide—Pharyngitis—Gemcitabine—pancreatic cancer	0.000508	0.00312	CcSEcCtD
Ciclesonide—Angioedema—Sunitinib—pancreatic cancer	0.000508	0.00312	CcSEcCtD
Ciclesonide—Haemoglobin—Fluorouracil—pancreatic cancer	0.000506	0.00311	CcSEcCtD
Ciclesonide—Rhinitis—Fluorouracil—pancreatic cancer	0.000505	0.0031	CcSEcCtD
Ciclesonide—Haemorrhage—Fluorouracil—pancreatic cancer	0.000504	0.00309	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.0005	0.034	CbGpPWpGaD
Ciclesonide—Pharyngitis—Fluorouracil—pancreatic cancer	0.0005	0.00307	CcSEcCtD
Ciclesonide—Cough—Sunitinib—pancreatic cancer	0.000485	0.00298	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000482	0.00296	CcSEcCtD
Ciclesonide—Hypertension—Sunitinib—pancreatic cancer	0.00048	0.00294	CcSEcCtD
Ciclesonide—Ulcer—Doxorubicin—pancreatic cancer	0.000478	0.00293	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000477	0.00293	CcSEcCtD
Ciclesonide—Immune system disorder—Irinotecan—pancreatic cancer	0.000475	0.00291	CcSEcCtD
Ciclesonide—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000474	0.00291	CcSEcCtD
Ciclesonide—Arthralgia—Sunitinib—pancreatic cancer	0.000473	0.0029	CcSEcCtD
Ciclesonide—Chest pain—Sunitinib—pancreatic cancer	0.000473	0.0029	CcSEcCtD
Ciclesonide—Dyspnoea—Tamoxifen—pancreatic cancer	0.000472	0.0029	CcSEcCtD
Ciclesonide—Nasopharyngitis—Docetaxel—pancreatic cancer	0.00047	0.00288	CcSEcCtD
Ciclesonide—Dyspnoea—Erlotinib—pancreatic cancer	0.000467	0.00287	CcSEcCtD
Ciclesonide—Candida infection—Epirubicin—pancreatic cancer	0.000466	0.00286	CcSEcCtD
Ciclesonide—Dyspepsia—Tamoxifen—pancreatic cancer	0.000466	0.00286	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000463	0.00284	CcSEcCtD
Ciclesonide—Dry mouth—Sunitinib—pancreatic cancer	0.000463	0.00284	CcSEcCtD
Ciclesonide—Immune system disorder—Gemcitabine—pancreatic cancer	0.000463	0.00284	CcSEcCtD
Ciclesonide—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000462	0.00283	CcSEcCtD
Ciclesonide—Dyspepsia—Erlotinib—pancreatic cancer	0.000461	0.00283	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000457	0.00281	CcSEcCtD
Ciclesonide—Fatigue—Tamoxifen—pancreatic cancer	0.000457	0.0028	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000452	0.00278	CcSEcCtD
Ciclesonide—Fatigue—Erlotinib—pancreatic cancer	0.000452	0.00277	CcSEcCtD
Ciclesonide—Infection—Sunitinib—pancreatic cancer	0.000451	0.00276	CcSEcCtD
Ciclesonide—Bronchospasm—Docetaxel—pancreatic cancer	0.000447	0.00274	CcSEcCtD
Ciclesonide—Back pain—Irinotecan—pancreatic cancer	0.000443	0.00272	CcSEcCtD
Ciclesonide—Back pain—Gemcitabine—pancreatic cancer	0.000431	0.00265	CcSEcCtD
Ciclesonide—Candida infection—Doxorubicin—pancreatic cancer	0.000431	0.00265	CcSEcCtD
Ciclesonide—Urticaria—Tamoxifen—pancreatic cancer	0.000421	0.00258	CcSEcCtD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.000418	0.0284	CbGpPWpGaD
Ciclesonide—Weight increased—Docetaxel—pancreatic cancer	0.000413	0.00254	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000413	0.00254	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.000411	0.028	CbGpPWpGaD
Ciclesonide—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000407	0.0025	CcSEcCtD
Ciclesonide—Pneumonia—Docetaxel—pancreatic cancer	0.000407	0.0025	CcSEcCtD
Ciclesonide—Infestation—Docetaxel—pancreatic cancer	0.000405	0.00248	CcSEcCtD
Ciclesonide—Infestation NOS—Docetaxel—pancreatic cancer	0.000405	0.00248	CcSEcCtD
Ciclesonide—Dyspnoea—Sunitinib—pancreatic cancer	0.000404	0.00248	CcSEcCtD
Ciclesonide—Cough—Irinotecan—pancreatic cancer	0.000399	0.00245	CcSEcCtD
Ciclesonide—Dyspepsia—Sunitinib—pancreatic cancer	0.000399	0.00245	CcSEcCtD
Ciclesonide—Hypertension—Irinotecan—pancreatic cancer	0.000395	0.00242	CcSEcCtD
Ciclesonide—Conjunctivitis—Docetaxel—pancreatic cancer	0.000394	0.00241	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000392	0.0024	CcSEcCtD
Ciclesonide—Fatigue—Sunitinib—pancreatic cancer	0.000391	0.0024	CcSEcCtD
Ciclesonide—Cough—Gemcitabine—pancreatic cancer	0.000389	0.00239	CcSEcCtD
Ciclesonide—Hypertension—Gemcitabine—pancreatic cancer	0.000385	0.00236	CcSEcCtD
Ciclesonide—Epistaxis—Docetaxel—pancreatic cancer	0.000382	0.00234	CcSEcCtD
Ciclesonide—Asthenia—Tamoxifen—pancreatic cancer	0.00038	0.00233	CcSEcCtD
Ciclesonide—Chest pain—Gemcitabine—pancreatic cancer	0.00038	0.00233	CcSEcCtD
Ciclesonide—Arthralgia—Gemcitabine—pancreatic cancer	0.00038	0.00233	CcSEcCtD
Ciclesonide—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000377	0.00231	CcSEcCtD
Ciclesonide—Asthenia—Erlotinib—pancreatic cancer	0.000376	0.00231	CcSEcCtD
Ciclesonide—Chest pain—Fluorouracil—pancreatic cancer	0.000373	0.00229	CcSEcCtD
Ciclesonide—Infection—Irinotecan—pancreatic cancer	0.000371	0.00228	CcSEcCtD
Ciclesonide—Haemoglobin—Docetaxel—pancreatic cancer	0.000365	0.00224	CcSEcCtD
Ciclesonide—Rhinitis—Docetaxel—pancreatic cancer	0.000364	0.00224	CcSEcCtD
Ciclesonide—Haemorrhage—Docetaxel—pancreatic cancer	0.000364	0.00223	CcSEcCtD
Ciclesonide—Infection—Gemcitabine—pancreatic cancer	0.000362	0.00222	CcSEcCtD
Ciclesonide—Pharyngitis—Docetaxel—pancreatic cancer	0.000361	0.00221	CcSEcCtD
Ciclesonide—Infection—Fluorouracil—pancreatic cancer	0.000355	0.00218	CcSEcCtD
Ciclesonide—Pain in extremity—Epirubicin—pancreatic cancer	0.000354	0.00217	CcSEcCtD
Ciclesonide—Dizziness—Tamoxifen—pancreatic cancer	0.00035	0.00215	CcSEcCtD
Ciclesonide—Dizziness—Erlotinib—pancreatic cancer	0.000346	0.00213	CcSEcCtD
Ciclesonide—Face oedema—Epirubicin—pancreatic cancer	0.000342	0.0021	CcSEcCtD
Ciclesonide—Rash—Tamoxifen—pancreatic cancer	0.000334	0.00205	CcSEcCtD
Ciclesonide—Dermatitis—Tamoxifen—pancreatic cancer	0.000334	0.00205	CcSEcCtD
Ciclesonide—Dyspnoea—Irinotecan—pancreatic cancer	0.000333	0.00204	CcSEcCtD
Ciclesonide—Headache—Tamoxifen—pancreatic cancer	0.000332	0.00204	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000332	0.00203	CcSEcCtD
Ciclesonide—Rash—Erlotinib—pancreatic cancer	0.00033	0.00203	CcSEcCtD
Ciclesonide—Dermatitis—Erlotinib—pancreatic cancer	0.00033	0.00202	CcSEcCtD
Ciclesonide—Dyspepsia—Irinotecan—pancreatic cancer	0.000329	0.00202	CcSEcCtD
Ciclesonide—Immune system disorder—Docetaxel—pancreatic cancer	0.000328	0.00201	CcSEcCtD
Ciclesonide—Headache—Erlotinib—pancreatic cancer	0.000328	0.00201	CcSEcCtD
Ciclesonide—Pain in extremity—Doxorubicin—pancreatic cancer	0.000328	0.00201	CcSEcCtD
Ciclesonide—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000328	0.00201	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000326	0.002	CcSEcCtD
Ciclesonide—Asthenia—Sunitinib—pancreatic cancer	0.000325	0.002	CcSEcCtD
Ciclesonide—Dyspnoea—Gemcitabine—pancreatic cancer	0.000324	0.00199	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000323	0.00198	CcSEcCtD
Ciclesonide—Fatigue—Irinotecan—pancreatic cancer	0.000322	0.00198	CcSEcCtD
Ciclesonide—Dyspnoea—Fluorouracil—pancreatic cancer	0.000319	0.00196	CcSEcCtD
Ciclesonide—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000317	0.00194	CcSEcCtD
Ciclesonide—Face oedema—Doxorubicin—pancreatic cancer	0.000317	0.00194	CcSEcCtD
Ciclesonide—Dyspepsia—Fluorouracil—pancreatic cancer	0.000315	0.00193	CcSEcCtD
Ciclesonide—Nausea—Tamoxifen—pancreatic cancer	0.000315	0.00193	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000314	0.00193	CcSEcCtD
Ciclesonide—Fatigue—Gemcitabine—pancreatic cancer	0.000314	0.00193	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000313	0.00192	CcSEcCtD
Ciclesonide—Nausea—Erlotinib—pancreatic cancer	0.000311	0.00191	CcSEcCtD
Ciclesonide—Dysgeusia—Docetaxel—pancreatic cancer	0.00031	0.0019	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—DAB2—pancreatic cancer	0.00031	0.0211	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000309	0.0019	CcSEcCtD
Ciclesonide—Influenza—Epirubicin—pancreatic cancer	0.000306	0.00188	CcSEcCtD
Ciclesonide—Back pain—Docetaxel—pancreatic cancer	0.000306	0.00188	CcSEcCtD
Ciclesonide—Dizziness—Sunitinib—pancreatic cancer	0.0003	0.00184	CcSEcCtD
Ciclesonide—Bronchitis—Epirubicin—pancreatic cancer	0.000295	0.00181	CcSEcCtD
Ciclesonide—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000293	0.0018	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000289	0.00177	CcSEcCtD
Ciclesonide—Rash—Sunitinib—pancreatic cancer	0.000286	0.00175	CcSEcCtD
Ciclesonide—Dermatitis—Sunitinib—pancreatic cancer	0.000286	0.00175	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000285	0.00175	CcSEcCtD
Ciclesonide—Urticaria—Fluorouracil—pancreatic cancer	0.000284	0.00174	CcSEcCtD
Ciclesonide—Headache—Sunitinib—pancreatic cancer	0.000284	0.00174	CcSEcCtD
Ciclesonide—Influenza—Doxorubicin—pancreatic cancer	0.000283	0.00174	CcSEcCtD
Ciclesonide—Palpitations—Docetaxel—pancreatic cancer	0.00028	0.00172	CcSEcCtD
Ciclesonide—Weight increased—Epirubicin—pancreatic cancer	0.000279	0.00171	CcSEcCtD
Ciclesonide—Cough—Docetaxel—pancreatic cancer	0.000276	0.00169	CcSEcCtD
Ciclesonide—Pneumonia—Epirubicin—pancreatic cancer	0.000275	0.00169	CcSEcCtD
Ciclesonide—Hypertension—Docetaxel—pancreatic cancer	0.000273	0.00168	CcSEcCtD
Ciclesonide—Infestation—Epirubicin—pancreatic cancer	0.000273	0.00168	CcSEcCtD
Ciclesonide—Infestation NOS—Epirubicin—pancreatic cancer	0.000273	0.00168	CcSEcCtD
Ciclesonide—Bronchitis—Doxorubicin—pancreatic cancer	0.000273	0.00167	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—NFE2L2—pancreatic cancer	0.000272	0.0185	CbGpPWpGaD
Ciclesonide—Arthralgia—Docetaxel—pancreatic cancer	0.000269	0.00165	CcSEcCtD
Ciclesonide—Chest pain—Docetaxel—pancreatic cancer	0.000269	0.00165	CcSEcCtD
Ciclesonide—Nausea—Sunitinib—pancreatic cancer	0.000269	0.00165	CcSEcCtD
Ciclesonide—Asthenia—Irinotecan—pancreatic cancer	0.000268	0.00164	CcSEcCtD
Ciclesonide—Conjunctivitis—Epirubicin—pancreatic cancer	0.000265	0.00163	CcSEcCtD
Ciclesonide—Urinary tract infection—Epirubicin—pancreatic cancer	0.000265	0.00163	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—TYMS—pancreatic cancer	0.000265	0.018	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.000264	0.0179	CbGpPWpGaD
Ciclesonide—Dry mouth—Docetaxel—pancreatic cancer	0.000263	0.00162	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000263	0.00162	CcSEcCtD
Ciclesonide—Asthenia—Gemcitabine—pancreatic cancer	0.000261	0.0016	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—TGFA—pancreatic cancer	0.000259	0.0176	CbGpPWpGaD
Ciclesonide—Weight increased—Doxorubicin—pancreatic cancer	0.000258	0.00158	CcSEcCtD
Ciclesonide—Epistaxis—Epirubicin—pancreatic cancer	0.000258	0.00158	CcSEcCtD
Ciclesonide—Infection—Docetaxel—pancreatic cancer	0.000257	0.00157	CcSEcCtD
Ciclesonide—Sinusitis—Epirubicin—pancreatic cancer	0.000256	0.00157	CcSEcCtD
Ciclesonide—Pneumonia—Doxorubicin—pancreatic cancer	0.000254	0.00156	CcSEcCtD
Ciclesonide—CES1—NRF2 pathway—SLC2A2—pancreatic cancer	0.000254	0.0172	CbGpPWpGaD
Ciclesonide—Infestation NOS—Doxorubicin—pancreatic cancer	0.000253	0.00155	CcSEcCtD
Ciclesonide—Infestation—Doxorubicin—pancreatic cancer	0.000253	0.00155	CcSEcCtD
Ciclesonide—Dizziness—Irinotecan—pancreatic cancer	0.000247	0.00152	CcSEcCtD
Ciclesonide—Haemoglobin—Epirubicin—pancreatic cancer	0.000246	0.00151	CcSEcCtD
Ciclesonide—Rhinitis—Epirubicin—pancreatic cancer	0.000246	0.00151	CcSEcCtD
Ciclesonide—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000246	0.00151	CcSEcCtD
Ciclesonide—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000246	0.00151	CcSEcCtD
Ciclesonide—Haemorrhage—Epirubicin—pancreatic cancer	0.000245	0.0015	CcSEcCtD
Ciclesonide—Pharyngitis—Epirubicin—pancreatic cancer	0.000243	0.00149	CcSEcCtD
Ciclesonide—Epistaxis—Doxorubicin—pancreatic cancer	0.000238	0.00146	CcSEcCtD
Ciclesonide—Sinusitis—Doxorubicin—pancreatic cancer	0.000237	0.00145	CcSEcCtD
Ciclesonide—Dizziness—Fluorouracil—pancreatic cancer	0.000237	0.00145	CcSEcCtD
Ciclesonide—Rash—Irinotecan—pancreatic cancer	0.000236	0.00145	CcSEcCtD
Ciclesonide—Dermatitis—Irinotecan—pancreatic cancer	0.000235	0.00144	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000235	0.00144	CcSEcCtD
Ciclesonide—Headache—Irinotecan—pancreatic cancer	0.000234	0.00144	CcSEcCtD
Ciclesonide—Dyspnoea—Docetaxel—pancreatic cancer	0.00023	0.00141	CcSEcCtD
Ciclesonide—Rash—Gemcitabine—pancreatic cancer	0.000229	0.00141	CcSEcCtD
Ciclesonide—Dermatitis—Gemcitabine—pancreatic cancer	0.000229	0.00141	CcSEcCtD
Ciclesonide—Haemoglobin—Doxorubicin—pancreatic cancer	0.000228	0.0014	CcSEcCtD
Ciclesonide—Headache—Gemcitabine—pancreatic cancer	0.000228	0.0014	CcSEcCtD
Ciclesonide—Rhinitis—Doxorubicin—pancreatic cancer	0.000227	0.0014	CcSEcCtD
Ciclesonide—Dyspepsia—Docetaxel—pancreatic cancer	0.000227	0.00139	CcSEcCtD
Ciclesonide—Haemorrhage—Doxorubicin—pancreatic cancer	0.000227	0.00139	CcSEcCtD
Ciclesonide—Rash—Fluorouracil—pancreatic cancer	0.000226	0.00138	CcSEcCtD
Ciclesonide—Dermatitis—Fluorouracil—pancreatic cancer	0.000225	0.00138	CcSEcCtD
Ciclesonide—Pharyngitis—Doxorubicin—pancreatic cancer	0.000225	0.00138	CcSEcCtD
Ciclesonide—Headache—Fluorouracil—pancreatic cancer	0.000224	0.00138	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000223	0.00137	CcSEcCtD
Ciclesonide—Fatigue—Docetaxel—pancreatic cancer	0.000223	0.00137	CcSEcCtD
Ciclesonide—Nausea—Irinotecan—pancreatic cancer	0.000222	0.00136	CcSEcCtD
Ciclesonide—Immune system disorder—Epirubicin—pancreatic cancer	0.000221	0.00136	CcSEcCtD
Ciclesonide—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000221	0.00136	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—PLAU—pancreatic cancer	0.000219	0.0149	CbGpPWpGaD
Ciclesonide—Nausea—Gemcitabine—pancreatic cancer	0.000216	0.00133	CcSEcCtD
Ciclesonide—Nausea—Fluorouracil—pancreatic cancer	0.000213	0.0013	CcSEcCtD
Ciclesonide—Dysgeusia—Epirubicin—pancreatic cancer	0.000209	0.00128	CcSEcCtD
Ciclesonide—Back pain—Epirubicin—pancreatic cancer	0.000206	0.00127	CcSEcCtD
Ciclesonide—Immune system disorder—Doxorubicin—pancreatic cancer	0.000205	0.00126	CcSEcCtD
Ciclesonide—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000204	0.00125	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—pancreatic cancer	0.000195	0.0133	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—HSPA1A—pancreatic cancer	0.000195	0.0133	CbGpPWpGaD
Ciclesonide—Dysgeusia—Doxorubicin—pancreatic cancer	0.000193	0.00119	CcSEcCtD
Ciclesonide—Back pain—Doxorubicin—pancreatic cancer	0.000191	0.00117	CcSEcCtD
Ciclesonide—Palpitations—Epirubicin—pancreatic cancer	0.000189	0.00116	CcSEcCtD
Ciclesonide—Cough—Epirubicin—pancreatic cancer	0.000186	0.00114	CcSEcCtD
Ciclesonide—Asthenia—Docetaxel—pancreatic cancer	0.000185	0.00114	CcSEcCtD
Ciclesonide—Hypertension—Epirubicin—pancreatic cancer	0.000184	0.00113	CcSEcCtD
Ciclesonide—Chest pain—Epirubicin—pancreatic cancer	0.000182	0.00111	CcSEcCtD
Ciclesonide—Arthralgia—Epirubicin—pancreatic cancer	0.000182	0.00111	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—RB1—pancreatic cancer	0.00018	0.0122	CbGpPWpGaD
Ciclesonide—Dry mouth—Epirubicin—pancreatic cancer	0.000178	0.00109	CcSEcCtD
Ciclesonide—Palpitations—Doxorubicin—pancreatic cancer	0.000175	0.00107	CcSEcCtD
Ciclesonide—Infection—Epirubicin—pancreatic cancer	0.000173	0.00106	CcSEcCtD
Ciclesonide—Cough—Doxorubicin—pancreatic cancer	0.000172	0.00106	CcSEcCtD
Ciclesonide—Dizziness—Docetaxel—pancreatic cancer	0.000171	0.00105	CcSEcCtD
Ciclesonide—Hypertension—Doxorubicin—pancreatic cancer	0.000171	0.00105	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—PTHLH—pancreatic cancer	0.00017	0.0115	CbGpPWpGaD
Ciclesonide—Arthralgia—Doxorubicin—pancreatic cancer	0.000168	0.00103	CcSEcCtD
Ciclesonide—Chest pain—Doxorubicin—pancreatic cancer	0.000168	0.00103	CcSEcCtD
Ciclesonide—CES1—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000166	0.0113	CbGpPWpGaD
Ciclesonide—Dry mouth—Doxorubicin—pancreatic cancer	0.000164	0.00101	CcSEcCtD
Ciclesonide—Rash—Docetaxel—pancreatic cancer	0.000163	0.000999	CcSEcCtD
Ciclesonide—Dermatitis—Docetaxel—pancreatic cancer	0.000163	0.000998	CcSEcCtD
Ciclesonide—Headache—Docetaxel—pancreatic cancer	0.000162	0.000993	CcSEcCtD
Ciclesonide—Infection—Doxorubicin—pancreatic cancer	0.00016	0.000982	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000159	0.000974	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—CDKN2A—pancreatic cancer	0.000158	0.0107	CbGpPWpGaD
Ciclesonide—Dyspnoea—Epirubicin—pancreatic cancer	0.000155	0.000953	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—EZH2—pancreatic cancer	0.000154	0.0105	CbGpPWpGaD
Ciclesonide—Nausea—Docetaxel—pancreatic cancer	0.000153	0.000941	CcSEcCtD
Ciclesonide—Dyspepsia—Epirubicin—pancreatic cancer	0.000153	0.000941	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00015	0.000923	CcSEcCtD
Ciclesonide—Fatigue—Epirubicin—pancreatic cancer	0.00015	0.000921	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000147	0.000901	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.000146	0.00991	CbGpPWpGaD
Ciclesonide—Dyspnoea—Doxorubicin—pancreatic cancer	0.000144	0.000882	CcSEcCtD
Ciclesonide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000142	0.000871	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00014	0.00954	CbGpPWpGaD
Ciclesonide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000139	0.000854	CcSEcCtD
Ciclesonide—Fatigue—Doxorubicin—pancreatic cancer	0.000139	0.000853	CcSEcCtD
Ciclesonide—Urticaria—Epirubicin—pancreatic cancer	0.000138	0.000849	CcSEcCtD
Ciclesonide—Urticaria—Doxorubicin—pancreatic cancer	0.000128	0.000786	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptors—PPARG—pancreatic cancer	0.000126	0.00858	CbGpPWpGaD
Ciclesonide—Asthenia—Epirubicin—pancreatic cancer	0.000125	0.000767	CcSEcCtD
Ciclesonide—NR3C1—Adipogenesis—AHR—pancreatic cancer	0.000122	0.00829	CbGpPWpGaD
Ciclesonide—Asthenia—Doxorubicin—pancreatic cancer	0.000116	0.00071	CcSEcCtD
Ciclesonide—Dizziness—Epirubicin—pancreatic cancer	0.000115	0.000707	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—SMAD4—pancreatic cancer	0.000114	0.00774	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.00011	0.00751	CbGpPWpGaD
Ciclesonide—NR3C1—Circadian Clock—HIF1A—pancreatic cancer	0.00011	0.00751	CbGpPWpGaD
Ciclesonide—Rash—Epirubicin—pancreatic cancer	0.00011	0.000674	CcSEcCtD
Ciclesonide—Dermatitis—Epirubicin—pancreatic cancer	0.00011	0.000673	CcSEcCtD
Ciclesonide—Headache—Epirubicin—pancreatic cancer	0.000109	0.00067	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—MYC—pancreatic cancer	0.000107	0.00728	CbGpPWpGaD
Ciclesonide—Dizziness—Doxorubicin—pancreatic cancer	0.000107	0.000654	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—pancreatic cancer	0.000104	0.00706	CbGpPWpGaD
Ciclesonide—Nausea—Epirubicin—pancreatic cancer	0.000103	0.000635	CcSEcCtD
Ciclesonide—Rash—Doxorubicin—pancreatic cancer	0.000102	0.000624	CcSEcCtD
Ciclesonide—Dermatitis—Doxorubicin—pancreatic cancer	0.000102	0.000623	CcSEcCtD
Ciclesonide—Headache—Doxorubicin—pancreatic cancer	0.000101	0.00062	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	9.97e-05	0.00678	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	9.9e-05	0.00673	CbGpPWpGaD
Ciclesonide—Nausea—Doxorubicin—pancreatic cancer	9.57e-05	0.000587	CcSEcCtD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	9.11e-05	0.00619	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—HIF1A—pancreatic cancer	9.11e-05	0.00619	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—GADD45A—pancreatic cancer	9.04e-05	0.00615	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—PLAU—pancreatic cancer	9.02e-05	0.00613	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—NOTCH1—pancreatic cancer	8.4e-05	0.00571	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—SST—pancreatic cancer	7.99e-05	0.00543	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NR5A2—pancreatic cancer	7.1e-05	0.00483	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CDKN2A—pancreatic cancer	6.51e-05	0.00443	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of Androgen receptor activity—SRC—pancreatic cancer	6.15e-05	0.00418	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—TGFB1—pancreatic cancer	6.14e-05	0.00417	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CXCL8—pancreatic cancer	5.91e-05	0.00402	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	5.72e-05	0.00389	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—CTNNB1—pancreatic cancer	5.58e-05	0.00379	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—HIF1A—pancreatic cancer	5.55e-05	0.00377	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCND1—pancreatic cancer	5.5e-05	0.00374	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—CTNNB1—pancreatic cancer	5.45e-05	0.0037	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP9—pancreatic cancer	5.34e-05	0.00363	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—PTEN—pancreatic cancer	5.31e-05	0.00361	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—pancreatic cancer	5.2e-05	0.00354	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	4.8e-05	0.00326	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—PPARG—pancreatic cancer	4.72e-05	0.00321	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	4.57e-05	0.0031	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—RB1—pancreatic cancer	4.52e-05	0.00307	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—TGFB1—pancreatic cancer	4.51e-05	0.00306	CbGpPWpGaD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	4.44e-05	0.00302	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MYC—pancreatic cancer	4.41e-05	0.003	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TGFB1—pancreatic cancer	4.4e-05	0.00299	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—CHD3—pancreatic cancer	4.08e-05	0.00277	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MEN1—pancreatic cancer	4.08e-05	0.00277	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	3.93e-05	0.00267	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	3.87e-05	0.00263	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TP53—pancreatic cancer	3.62e-05	0.00246	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NR5A2—pancreatic cancer	3.42e-05	0.00232	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—CTNNB1—pancreatic cancer	3.32e-05	0.00226	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	3.29e-05	0.00224	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	3.19e-05	0.00217	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	3.11e-05	0.00212	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	2.98e-05	0.00202	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—STAT3—pancreatic cancer	2.89e-05	0.00197	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	2.87e-05	0.00195	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	2.72e-05	0.00185	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	2.7e-05	0.00183	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	2.68e-05	0.00182	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	2.53e-05	0.00172	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—pancreatic cancer	2.51e-05	0.0017	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	2.48e-05	0.00168	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	2.17e-05	0.00147	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MEN1—pancreatic cancer	1.96e-05	0.00134	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	1.86e-05	0.00127	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	1.83e-05	0.00124	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	1.78e-05	0.00121	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	1.72e-05	0.00117	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—EZH2—pancreatic cancer	1.62e-05	0.0011	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	1.58e-05	0.00108	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	1.5e-05	0.00102	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.35e-05	0.000915	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—SMAD4—pancreatic cancer	1.19e-05	0.000811	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.17e-05	0.000793	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.02e-05	0.000693	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	9.82e-06	0.000668	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PRSS1—pancreatic cancer	8.8e-06	0.000598	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	8.79e-06	0.000597	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PPARG—pancreatic cancer	8.29e-06	0.000564	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GLP1R—pancreatic cancer	8.22e-06	0.000559	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—DPYD—pancreatic cancer	8.09e-06	0.00055	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	7.68e-06	0.000522	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ARG2—pancreatic cancer	7.63e-06	0.000519	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TYMP—pancreatic cancer	6.67e-06	0.000453	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CD44—pancreatic cancer	5.94e-06	0.000404	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GCG—pancreatic cancer	5.7e-06	0.000387	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.38e-06	0.000365	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—STK11—pancreatic cancer	5.36e-06	0.000364	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.29e-06	0.00036	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5.02e-06	0.000341	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—pancreatic cancer	4.73e-06	0.000321	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.61e-06	0.000313	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CD44—pancreatic cancer	3.89e-06	0.000264	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOE—pancreatic cancer	3.75e-06	0.000255	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GCG—pancreatic cancer	3.73e-06	0.000253	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—STK11—pancreatic cancer	3.5e-06	0.000238	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.38e-06	0.00023	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—AKT1—pancreatic cancer	3.28e-06	0.000223	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.27e-06	0.000222	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.01e-06	0.000205	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.97e-06	0.000202	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.59e-06	0.000176	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.57e-06	0.000175	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOE—pancreatic cancer	2.45e-06	0.000167	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.24e-06	0.000152	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.21e-06	0.00015	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.13e-06	0.000145	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.94e-06	0.000132	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.69e-06	0.000115	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.68e-06	0.000114	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.58e-06	0.000107	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.46e-06	9.96e-05	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.29e-06	8.78e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.03e-06	7.02e-05	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.44e-07	5.74e-05	CbGpPWpGaD
